GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » ROC (Joel Greenblatt) %

Eckert & Ziegler SE (XTER:EUZ) ROC (Joel Greenblatt) % : 28.43% (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Eckert & Ziegler SE's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 28.43%.

The historical rank and industry rank for Eckert & Ziegler SE's ROC (Joel Greenblatt) % or its related term are showing as below:

XTER:EUZ' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 24.17   Med: 33.52   Max: 47.65
Current: 28.29

During the past 13 years, Eckert & Ziegler SE's highest ROC (Joel Greenblatt) % was 47.65%. The lowest was 24.17%. And the median was 33.52%.

XTER:EUZ's ROC (Joel Greenblatt) % is ranked better than
79.23% of 852 companies
in the Medical Devices & Instruments industry
Industry Median: 1.75 vs XTER:EUZ: 28.29

Eckert & Ziegler SE's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -5.40% per year.


Eckert & Ziegler SE ROC (Joel Greenblatt) % Historical Data

The historical data trend for Eckert & Ziegler SE's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE ROC (Joel Greenblatt) % Chart

Eckert & Ziegler SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.89 36.39 47.65 37.42 27.33

Eckert & Ziegler SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.79 20.61 28.64 32.02 28.43

Competitive Comparison of Eckert & Ziegler SE's ROC (Joel Greenblatt) %

For the Medical Devices subindustry, Eckert & Ziegler SE's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE's ROC (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's ROC (Joel Greenblatt) % falls into.



Eckert & Ziegler SE ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(51.152 + 45.834 + 86.085) - (14.194 + 0 + 68.066)
=100.811

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(39.69 + 45.649 + 86.503) - (19.256 + 0 + 71.444)
=81.142

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Eckert & Ziegler SE for the quarter that ended in Sep. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=59.06/( ( (117.601 + max(100.811, 0)) + (115.857 + max(81.142, 0)) )/ 2 )
=59.06/( ( 218.412 + 196.999 )/ 2 )
=59.06/207.7055
=28.43 %

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eckert & Ziegler SE  (XTER:EUZ) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Eckert & Ziegler SE ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.
Executives
Dr. Andreas Eckert Supervisory Board
Frank Perschmann Supervisory Board
Dr. Hakim Bouterfa Board of Directors
Prof. Dr. Wolfgang Maennig Supervisory Board
Dr. Harald Hasselmann Board of Directors

Eckert & Ziegler SE Headlines

No Headlines